Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors.
Child, Preschool
Diagnosis, Differential
Diffusion Magnetic Resonance Imaging
/ methods
Feasibility Studies
Female
Ganglioneuroma
/ diagnostic imaging
Humans
Image Interpretation, Computer-Assisted
/ methods
Male
Neoadjuvant Therapy
Neuroblastoma
/ diagnostic imaging
Predictive Value of Tests
Reproducibility of Results
Retrospective Studies
Software
Tumor Burden
Diagnostic imaging
Diffusion magnetic resonance imaging
Magnetic resonance imaging
Neuroblastoma
Journal
Cancer imaging : the official publication of the International Cancer Imaging Society
ISSN: 1470-7330
Titre abrégé: Cancer Imaging
Pays: England
ID NLM: 101172931
Informations de publication
Date de publication:
17 Dec 2020
17 Dec 2020
Historique:
received:
15
02
2020
accepted:
08
12
2020
entrez:
18
12
2020
pubmed:
19
12
2020
medline:
25
3
2021
Statut:
epublish
Résumé
To assess the feasibility and possible value of semi-automated diffusion weighted imaging (DWI) volumetry of whole neuroblastic tumors with apparent diffusion coefficient (ADC) map evaluation after neoadjuvant chemotherapy. Pediatric patients who underwent surgical resection of neuroblastic tumors at our institution from 2013 to 2019 and who received a preoperative MRI scan with DWI after chemotherapy were included. Tumor volume was assessed with a semi-automated approach in DWI using a dedicated software prototype. Quantitative ADC values were calculated automatically of the total tumor volume after manual exclusion of necrosis. Manual segmentation in T1 weighted and T2 weighted sequences was used as reference standard for tumor volume comparison. The Student's t test was used for parametric data while the Wilcoxon rank sum test and the Kruskal-Wallis test were applied for non-parametric data. Twenty seven patients with 28 lesions (neuroblastoma (NB): n = 19, ganglioneuroblastoma (GNB): n = 7, ganglioneuroma (GN): n = 2) could be evaluated. Mean patient age was 4.5 ± 3.2 years. Median volume of standard volumetry (T1w or T2w) was 50.2 ml (interquartile range (IQR): 91.9 ml) vs. 45.1 ml (IQR: 98.4 ml) of DWI (p = 0.145). Mean ADC values (× 10 Quantitative semi-automated DWI volumetry is feasible in neuroblastic tumors with integrated analysis of tissue characteristics by providing automatically calculated ADC values of the whole tumor as well as an ADC heatmap. The 5th percentile of the ADC values of the whole tumor volume proved to be the most significant parameter for differentiation of the histopathological subtypes in our patient cohort and further investigation seems to be worthwhile.
Sections du résumé
BACKGROUND
BACKGROUND
To assess the feasibility and possible value of semi-automated diffusion weighted imaging (DWI) volumetry of whole neuroblastic tumors with apparent diffusion coefficient (ADC) map evaluation after neoadjuvant chemotherapy.
METHODS
METHODS
Pediatric patients who underwent surgical resection of neuroblastic tumors at our institution from 2013 to 2019 and who received a preoperative MRI scan with DWI after chemotherapy were included. Tumor volume was assessed with a semi-automated approach in DWI using a dedicated software prototype. Quantitative ADC values were calculated automatically of the total tumor volume after manual exclusion of necrosis. Manual segmentation in T1 weighted and T2 weighted sequences was used as reference standard for tumor volume comparison. The Student's t test was used for parametric data while the Wilcoxon rank sum test and the Kruskal-Wallis test were applied for non-parametric data.
RESULTS
RESULTS
Twenty seven patients with 28 lesions (neuroblastoma (NB): n = 19, ganglioneuroblastoma (GNB): n = 7, ganglioneuroma (GN): n = 2) could be evaluated. Mean patient age was 4.5 ± 3.2 years. Median volume of standard volumetry (T1w or T2w) was 50.2 ml (interquartile range (IQR): 91.9 ml) vs. 45.1 ml (IQR: 98.4 ml) of DWI (p = 0.145). Mean ADC values (× 10
CONCLUSIONS
CONCLUSIONS
Quantitative semi-automated DWI volumetry is feasible in neuroblastic tumors with integrated analysis of tissue characteristics by providing automatically calculated ADC values of the whole tumor as well as an ADC heatmap. The 5th percentile of the ADC values of the whole tumor volume proved to be the most significant parameter for differentiation of the histopathological subtypes in our patient cohort and further investigation seems to be worthwhile.
Identifiants
pubmed: 33334369
doi: 10.1186/s40644-020-00366-3
pii: 10.1186/s40644-020-00366-3
pmc: PMC7745476
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
89Références
Hell J Nucl Med. 2015 May-Aug;18(2):97-102
pubmed: 26187207
Pediatr Radiol. 2018 Aug;48(9):1337-1347
pubmed: 30078048
Diagn Interv Radiol. 2016 Jul-Aug;22(4):390-4
pubmed: 27306659
Eur Radiol Exp. 2019 Jan 30;3(1):6
pubmed: 30701332
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):2009-2024
pubmed: 29938300
Pediatr Blood Cancer. 2016 Oct;63(10):1786-93
pubmed: 27304424
Clin Nucl Med. 2017 Mar;42(3):e142-e148
pubmed: 28072621
Pediatr Radiol. 2018 Aug;48(9):1324-1336
pubmed: 30078040
Jpn J Radiol. 2016 Sep;34(9):620-4
pubmed: 27418194
Pediatr Blood Cancer. 2017 Nov;64(11):
pubmed: 28440012
AJR Am J Roentgenol. 2003 Oct;181(4):1115-24
pubmed: 14500242
Radiographics. 2018 Mar-Apr;38(2):566-580
pubmed: 29528815
N Engl J Med. 2010 Jun 10;362(23):2202-11
pubmed: 20558371
J Clin Oncol. 2009 Jan 10;27(2):289-97
pubmed: 19047291
J Clin Oncol. 2013 Feb 20;31(6):752-8
pubmed: 23284039
J Pediatr Surg. 2004 Mar;39(3):412-7; discussion 412-7
pubmed: 15017562
Clin Nucl Med. 2015 Sep;40(9):737-9
pubmed: 26053707
Cochrane Database Syst Rev. 2015 Sep 29;(9):CD009263
pubmed: 26417712
J Pediatr Hematol Oncol. 2016 Oct;38(7):e263-6
pubmed: 27571120
Pediatr Radiol. 2013 Apr;43(4):418-27
pubmed: 23151727
Pediatr Blood Cancer. 2015 Sep;62(9):1543-9
pubmed: 25820608
Rofo. 2017 Jul;189(7):640-650
pubmed: 28511265
Radiology. 2011 Oct;261(1):243-57
pubmed: 21586679
Diagn Interv Radiol. 2017 Sep-Oct;23(5):403-406
pubmed: 28830846
Eur J Radiol. 2011 Sep;79(3):443-6
pubmed: 20462716